COMMUNIQUÉS West-GlobeNewswire

$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment

10/10/2024 - 16:00

DENVER, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Unyte Health, Inc., a leader in health technology and nervous system regulation-based listening therapy, is proud to announce that the United States Department of Defense has [...]

BioPorto Announces Appointment of National Principal Investigator and Selection of CRO for Upcoming USA ICU Adult AKI Clinical Study

10/10/2024 - 16:17

October 10 , 2024 News Release BioPorto A nnounces Appointment of National Principal Investigator and S election of CRO for U pcoming US A ICU Adult AKI C linical S tudy COPENHAGEN, Denmark and BOSTON, MA, USA, October [...]

Press release: Transparency Notification from Shareholders

10/10/2024 - 17:40

Transparency Notification from Shareholders Ghent, Belgium – 10 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid overload in [...]

Renowned Hypnotherapist Dr. Steve G. Jones Brings Hollywood's Best-Kept Wealth Secret to the Public

10/10/2024 - 17:57

Dr. Steve G. Jones Introduces a Neuroscience-Based Method Aimed at Transforming Financial Mindsets for Everyday Individuals BEVERLY HILLS, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Dr. Steve G. Jones, a world-renowned [...]

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 8 octobre 2024

10/10/2024 - 18:00

Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 – Symbole : PHXM) Site web : www.phaxiam.com Date Nombre total d’actions composant le capital social Nombre total de droits de vote brut (1) [...]

Monthly information related to total number of voting rights and shares composing the share capital – October 8, 2024

10/10/2024 - 18:00

Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com Date Total of shares composing the share capital Total of brut (1) voting rights Total of net ( 2) [...]

Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice

10/10/2024 - 18:24

ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– is announcing the retirement of Dr. David Olanksy, a trusted expert in the field of dermatology [...]

QC Kinetix Celebrates PA Week Honoring Physician Assistants as 'The Miraculous Midlevel'

10/10/2024 - 19:08

QC Kinetix, a fast-growing regenerative medicine franchise that offers a cutting-edge, non-surgical alternative to joint and pain relief, recognizes PA Week Charlotte, North Carolina, Oct. 10, 2024 (GLOBE NEWSWIRE) -- [...]

EUROAPI finalise le financement de son plan FOCUS-27 et poursuit son exécution

10/10/2024 - 20:38

Communiqué de presse Contrat de crédit RCF de €451M refinancé avec une maturité étendue à février 2029 Obligation Hybride Super Subordonnée de €200M souscrite par Sanofi Accord de €54M conclu avec Sanofi pour la [...]

EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution

10/10/2024 - 20:38

Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029 Issuance of a €200M Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi €54M product capacity reservation for [...]

Appili Therapeutics – Press Release Correction

10/10/2024 - 21:40

HALIFAX, Nova Scotia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), announces correction to its press release entitled “Appili Therapeutics Announces [...]

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers

10/10/2024 - 22:02

– Subcutaneously administered AK006 showed approximately 77% bioavailability and prolonged receptor occupancy on mast cells – – Subcutaneous AK006 was well-tolerated with a favorable safety profile – – Top-line Phase 1 [...]

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum

10/10/2024 - 22:05

Proprietary cell-free platform enables the design of next-generation ADCs intended to broaden addressable patient populations STRO-004 (tissue factor ADC) preclinical data has demonstrated greater anti-tumor activity [...]

Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor

10/10/2024 - 22:05

Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by Ascensia Diabetes Care [...]

SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

10/10/2024 - 22:05

NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a [...]

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications

10/10/2024 - 22:05

Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 [...]

PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024

10/10/2024 - 22:05

MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on Thursday, November 7, [...]

Codexis to Report Third Quarter 2024 Financial Results on October 31

10/10/2024 - 22:05

REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report [...]

Procedure of the Annual General Meeting

10/10/2024 - 22:35

ANNOUNCEMENT NO. 277 10 October 2024 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 10 October 2024 at 5.30 p.m. at Nordsjællands KonferenceCenter. At the Annual General [...]